Literature DB >> 8632077

Favorable prognostic factors in recurrent and metastatic melanoma.

R A Buzzell1, J A Zitelli.   

Abstract

Survival among patients with recurrent and metastatic melanoma varies widely. Several clinical and pathologic variables correlate with improved survival. Awareness of these favorable prognostic characteristics should assist in patient counseling and help identify those who may benefit from more aggressive therapeutic intervention.

Entities:  

Mesh：

Year:  1996        PMID： 8632077     DOI： 10.1016/s0190-9622(96)90017-1

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


  4 in total

1.  Metastatic malignant melanoma presenting as malabsorption.

Authors:  C Baliellas; X Pagerols; N Curcó; M García-Font; M Forné; P Vives
Journal:  Dig Dis Sci       Date:  2002-01       Impact factor: 3.199

2.  Accuracy of real-time ultrasound elastography in the differential diagnosis of lymph nodes in cutaneous malignant melanoma (CMM): a pilot study.

Authors:  Dai Ogata; Takayoshi Uematsu; Shusuke Yoshikawa; Yoshio Kiyohara
Journal:  Int J Clin Oncol       Date:  2013-07-31       Impact factor: 3.402

3.  Preoperative ultrasound is not useful for identifying nodal metastasis in melanoma patients undergoing sentinel node biopsy: preoperative ultrasound in clinically node-negative melanoma.

Authors:  Christy Y Chai; Jonathan S Zager; Margaret M Szabunio; Suroosh S Marzban; Alec Chau; Robert M Rossi; Vernon K Sondak
Journal:  Ann Surg Oncol       Date:  2011-12-23       Impact factor: 5.344

4.  Melanoma patients with unknown primary site or nodal recurrence after initial diagnosis have a favourable survival compared to those with synchronous lymph node metastasis and primary tumour.

Authors:  Benjamin Weide; Christine Faller; Margrit Elsässer; Petra Büttner; Annette Pflugfelder; Ulrike Leiter; Thomas Kurt Eigentler; Jürgen Bauer; Friedegund Meier; Claus Garbe
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.